Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1919 1
1920 1
1925 2
1936 2
1942 1
1952 1
1958 1
1959 1
1961 3
1963 3
1964 5
1966 5
1967 2
1968 1
1969 1
1970 5
1971 3
1972 5
1973 3
1974 4
1975 7
1976 9
1977 8
1978 3
1979 11
1980 6
1981 9
1982 9
1983 6
1984 10
1985 9
1986 5
1987 2
1988 7
1989 6
1990 6
1991 7
1992 5
1993 2
1994 4
1995 8
1996 8
1997 14
1998 16
1999 14
2000 17
2001 9
2002 19
2003 12
2004 24
2005 26
2006 28
2007 37
2008 54
2009 84
2010 87
2011 64
2012 89
2013 98
2014 116
2015 136
2016 117
2017 164
2018 128
2019 133
2020 142
2021 184
2022 252
2023 238
2024 71

Text availability

Article attribute

Article type

Publication date

Search Results

2,322 results

Results by year

Filters applied: . Clear all
Page 1
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial.
Armstrong AW, Gooderham M, Warren RB, Papp KA, Strober B, Thaçi D, Morita A, Szepietowski JC, Imafuku S, Colston E, Throup J, Kundu S, Schoenfeld S, Linaberry M, Banerjee S, Blauvelt A. Armstrong AW, et al. Among authors: kundu s. J Am Acad Dermatol. 2023 Jan;88(1):29-39. doi: 10.1016/j.jaad.2022.07.002. Epub 2022 Jul 9. J Am Acad Dermatol. 2023. PMID: 35820547 Free article. Clinical Trial.
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022.
Flaig TW, Spiess PE, Abern M, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Chan K, Chang S, Friedlander T, Greenberg RE, Guru KA, Herr HW, Hoffman-Censits J, Kishan A, Kundu S, Lele SM, Mamtani R, Margulis V, Mian OY, Michalski J, Montgomery JS, Nandagopal L, Pagliaro LC, Parikh M, Patterson A, Plimack ER, Pohar KS, Preston MA, Richards K, Sexton WJ, Siefker-Radtke AO, Tollefson M, Tward J, Wright JL, Dwyer MA, Cassara CJ, Gurski LA. Flaig TW, et al. Among authors: kundu s. J Natl Compr Canc Netw. 2022 Aug;20(8):866-878. doi: 10.6004/jnccn.2022.0041. J Natl Compr Canc Netw. 2022. PMID: 35948037
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial.
Strober B, Thaçi D, Sofen H, Kircik L, Gordon KB, Foley P, Rich P, Paul C, Bagel J, Colston E, Throup J, Kundu S, Sekaran C, Linaberry M, Banerjee S, Papp KA. Strober B, et al. Among authors: kundu s. J Am Acad Dermatol. 2023 Jan;88(1):40-51. doi: 10.1016/j.jaad.2022.08.061. Epub 2022 Sep 14. J Am Acad Dermatol. 2023. PMID: 36115523 Free article. Clinical Trial.
Integrative single-cell analysis of cardiogenesis identifies developmental trajectories and non-coding mutations in congenital heart disease.
Ameen M, Sundaram L, Shen M, Banerjee A, Kundu S, Nair S, Shcherbina A, Gu M, Wilson KD, Varadarajan A, Vadgama N, Balsubramani A, Wu JC, Engreitz JM, Farh K, Karakikes I, Wang KC, Quertermous T, Greenleaf WJ, Kundaje A. Ameen M, et al. Among authors: kundu s. Cell. 2022 Dec 22;185(26):4937-4953.e23. doi: 10.1016/j.cell.2022.11.028. Cell. 2022. PMID: 36563664 Free PMC article.
EDITORIAL COMMENT.
Sweis J, Kundu SD, Murphy AB. Sweis J, et al. Among authors: kundu sd. Urology. 2023 May;175:148-149. doi: 10.1016/j.urology.2022.12.059. Urology. 2023. PMID: 37257986 No abstract available.
Single-nucleus chromatin accessibility profiling highlights regulatory mechanisms of coronary artery disease risk.
Turner AW, Hu SS, Mosquera JV, Ma WF, Hodonsky CJ, Wong D, Auguste G, Song Y, Sol-Church K, Farber E, Kundu S, Kundaje A, Lopez NG, Ma L, Ghosh SKB, Onengut-Gumuscu S, Ashley EA, Quertermous T, Finn AV, Leeper NJ, Kovacic JC, Björkegren JLM, Zang C, Miller CL. Turner AW, et al. Among authors: kundu s. Nat Genet. 2022 Jun;54(6):804-816. doi: 10.1038/s41588-022-01069-0. Epub 2022 May 19. Nat Genet. 2022. PMID: 35590109 Free PMC article.
Unimon qubit.
Hyyppä E, Kundu S, Chan CF, Gunyhó A, Hotari J, Janzso D, Juliusson K, Kiuru O, Kotilahti J, Landra A, Liu W, Marxer F, Mäkinen A, Orgiazzi JL, Palma M, Savytskyi M, Tosto F, Tuorila J, Vadimov V, Li T, Ockeloen-Korppi C, Heinsoo J, Tan KY, Hassel J, Möttönen M. Hyyppä E, et al. Among authors: kundu s. Nat Commun. 2022 Nov 12;13(1):6895. doi: 10.1038/s41467-022-34614-w. Nat Commun. 2022. PMID: 36371435 Free PMC article.
Editorial Comment.
Greenberg DR, Kundu SD. Greenberg DR, et al. Among authors: kundu sd. J Urol. 2023 Nov;210(5):769-770. doi: 10.1097/JU.0000000000003639.01. Epub 2023 Aug 25. J Urol. 2023. PMID: 37622524 No abstract available.
Ferroelectricity in Hybrid Perovskites.
Manzi M, Pica G, De Bastiani M, Kundu S, Grancini G, Saidaminov MI. Manzi M, et al. Among authors: kundu s. J Phys Chem Lett. 2023 Apr 13;14(14):3535-3552. doi: 10.1021/acs.jpclett.3c00566. Epub 2023 Apr 5. J Phys Chem Lett. 2023. PMID: 37017277 Review.
2,322 results